Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,658,367 papers from all fields of science
Search
Sign In
Create Free Account
Combined hyperlipidemia
Known as:
Combined hyperlipidaemia
, Multiple-type hyperlipoproteinemia
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Коррекция нарушений липидного обмена у пожилых пациентов с сахарным диабетом 2-го типа
Л. Г. Гонохова
2018
Corpus ID: 80790142
Aim. To study simvastatin effects on lipid metabolism in elderly patients with Type 2 diabetes mellitus (DM-2) and isolated…
Expand
2014
2014
[Comparison of serum lipid and protein oxidation products levels in patients with different types of dyslipidemia].
Guirong Wu
,
M. Cheserek
,
Yong-hui Shi
,
Jinfeng Liu
,
Li-hua Wang
,
G. Le
Wei sheng yan jiu = Journal of hygiene research
2014
Corpus ID: 10550024
OBJECTIVE To explore serum redox status differences among different types of dyslipidemia patients. METHOD One hundred and…
Expand
Review
2007
Review
2007
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?
V. Athyros
,
K. Tziomalos
,
+5 authors
A. Karagiannis
Expert Opinion on Pharmacotherapy
2007
Corpus ID: 26041691
This review considers the treatment for combined hyperlipidaemia (CH) with a combination formulation of three drugs: a statin…
Expand
2004
2004
Apolipoprotein E polymorphism and lipoprotein levels in a Gulf Arab population in Kuwait: a pilot study
S. Al-Shammari
,
H. Fatania
,
R. Al-Radwan
,
A. Akanji
Annals of Saudi Medicine
2004
Corpus ID: 26067049
Background APOE polymorphism is believed to confer susceptibility to coronary heart disease (CHD) and Alzheimer’s disease. It is…
Expand
2002
2002
Linkage and association of haplotypes at the APOA1/C3/A4/A5 gene cluster to familial combined hyperlipidemia
S. Eichenbaum‐Voline
,
M. Olivier
,
+11 authors
L. Pennacchio
2002
Corpus ID: 55321369
Combined hyperlipidemia (CHL) is a common disorder of lipid metabolism that leads to an increased risk of cardiovascular disease…
Expand
1998
1998
Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism
Hoffer
,
Sijbrands
,
De Man
,
Havekes
,
Smelt
,
Frants
European Journal of Clinical Investigation
1998
Corpus ID: 42964513
Hypertriglyceridaemia is a common metabolic disorder frequently found in patients with coronary heart disease. Numerous studies…
Expand
1995
1995
Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.
G. Shen
,
D. Mymin
,
T. Dembinski
,
A. Krahn
,
A. Angel
Clinical and investigative medicine. Medecine…
1995
Corpus ID: 27433553
This study demonstrates that peripheral apolipoprotein(a) [apo(a)] levels are higher in patients with polygenic…
Expand
1994
1994
Gemfibrozil vs lovastatin in combined hyperlipidemia (CHL)
C. Rodríguez
,
C. Sanllehy
,
E. Casals
,
E. Ros
1994
Corpus ID: 57644555
1991
1991
Alternative fat-restricted diets for hypercholesterolemia and combined hyperlipidemia: feasibility, design, subject recruitment, and baseline characteristics of the dietary alternatives study.
C. Walden
,
B. Mccann
,
+7 authors
G. Gey
Journal of the American College of Nutrition
1991
Corpus ID: 25538662
UNLABELLED Dietary recommendations for the treatment of hypercholesterolemia (HC) emphasize stepwise reductions in fat intake…
Expand
1987
1987
Effects of Bezafibrate on Lipoprotein Metabolism in Cell Culture
S. Eisenberg
1987
Corpus ID: 68266477
Bezafibrate (BZ) is an efficient lipid-lowering drug that is effective in several types of hyperlipidemia (1). BZ reduces high…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE